Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant tumor with great variation in prognosis among individuals. Changes in metabolism influence disease progression and clinical outcomes. The objective of this study was to determine the overall survival (OS) risk of HCC patients from a metabolic...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Hepatocell Carcinoma
Auteurs principaux: Weng, Jialei, Zhou, Chenhao, Zhou, Qiang, Chen, Wanyong, Yin, Yirui, Atyah, Manar, Dong, Qiongzhu, Shi, Yi, Ren, Ning
Format: Artigo
Langue:Inglês
Publié: Dove 2021
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018394/
https://ncbi.nlm.nih.gov/pubmed/33824863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S300633
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires